S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes

JL Eisenbacher, H Schrezenmeier… - The Journal of …, 2014 - journals.aai.org
JL Eisenbacher, H Schrezenmeier, B Jahrsdörfer, C Kaltenmeier, MT Rojewski, T Yildiz…
The Journal of Immunology, 2014journals.aai.org
Simple stress or necrotic cell death with subsequent release of damage-associated
molecular patterns (DAMPs) is a characteristic feature of most advanced tumors. DAMPs
within the tumor microenvironment stimulate tumor-associated cells, including dendritic cells
and mesenchymal stromal cells (MSCs). The presence of tumor-infiltrating MSCs is
associated with tumor progression and metastasis. Oxidized necrotic material loses its
stimulatory capacity for MSCs. As a DAMP, S100A4 is sensitive to oxidation whereas uric …
Abstract
Simple stress or necrotic cell death with subsequent release of damage-associated molecular patterns (DAMPs) is a characteristic feature of most advanced tumors. DAMPs within the tumor microenvironment stimulate tumor-associated cells, including dendritic cells and mesenchymal stromal cells (MSCs). The presence of tumor-infiltrating MSCs is associated with tumor progression and metastasis. Oxidized necrotic material loses its stimulatory capacity for MSCs. As a DAMP, S100A4 is sensitive to oxidation whereas uric acid (UA) acts primarily as an antioxidant. We tested these two biologic moieties separately and in combination for their activity on MSCs. Similar to necrotic tumor material, S100A4 and UA both dose-dependently induced chemotaxis of MSCs with synergistic effects when combined. Substituting for UA, alternative antioxidants (vitamin C, DTT, and N-acetylcysteine) also enhanced the chemotactic activity of S100A4 in a synergistic manner. This emphasizes the reducing potential of UA being, at least in part, responsible for the observed synergy. With regard to MSC proliferation, both S100A4 and UA inhibited MSCs without altering survival or inducing differentiation toward adipo-, osteo-, or chondrocytes. In the presence of S100A4 or UA, MSCs gained an immunosuppressive capability and stably induced IL-10–and IDO-expressing lymphocytes that maintained their phenotype following proliferation. We have thus demonstrated that both S100A4 and UA act as DAMPs and, as such, may play a critical role in promoting some aspects of MSC-associated immunoregulation. Our findings have implications for therapeutic approaches targeting the tumor microenvironment and addressing the immunosuppressive nature of unscheduled cell death within the tumor microenvironment.
journals.aai.org